NGS Sample Preparation Market – Huge Revenue Growth is Expected by 2024

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the NGS Sample Preparation Procedure Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The key players in the industry and markets have been identified through extensive secondary research.

The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.

All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation:

After arriving at the overall market size-using the market size estimation processes as explained above-the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the NGS sample preparation market.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=69735098

Recent Developments:

In 2019, QIAGEN N.V. launched its QIAcube Connect.

In 2018, Thermo Fisher Scientific (US) launched its Oncomine Childhood Cancer Research Assay, a comprehensive, next-generation sequencing (NGS) panel.

In 2018, Illumina entered into an agreement to acquire Pacific Biosciences.

In 2018, Tecan acquired NuGEN Technologies, Inc., a US-based sequencing sample prep company.

North America dominated the NGS sample preparation market in 2018

Geographically, the NGS Sample Preparation Procedure Market is segmented into North America (US and Canada), Europe (Germany, France, the UK, and the Rest of Europe), Asia Pacific (China, Japan, India, and the Rest of Asia Pacific), and the Rest of the World (RoW). North America accounted for the largest share of the overall NGS sample preparation market in 2018 followed by Europe.

The large share of North America can be attributed to the favorable initiatives by government and private bodies for the development and adoption of NGS technologies, wide adoption of NGS diagnostics in the region, increasing number of NGS-based research & clinical applications in the region, growing research on cancer, rising awareness of NGS services, and the presence of leading NGS service providers, in the region.

Key questions addressed in the report:

What are the growth opportunities related to the NGS sample preparation market across major regions in the future?
Emerging countries have immense opportunities for the growth and adoption of NGS sample preparation products. Will this scenario continue in the next five years?
What are the various NGS sample preparation product segments and their market share in the overall market?
What are the new trends and advancements in the market?
How will the use of NGS in diagnostics impact the overall adoption and industry of NGS sample preparation products?

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=69735098

Global Leaders:

Some of the prominent players in the NGS sample preparation market include Illumina Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), Beckman Coulter (a subsidiary of Danaher), Becton, Dickinson and Company (BD) (US), Pacific Biosciences of California (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche (Switzerland), and New England Biolabs, Inc. (US), among others.

Analysis of the developments in the NGS sample preparation market from 2016 to 2018 shows that product launches; agreements, partnerships and collaborations; expansions; and acquisitions were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positions.

Illumina dominates the NGS Sample Preparation Procedure Market with its technologically advanced platforms and associated NGS products. The company’s product portfolio includes a wide range of highly interconnected products including sequencing, genotyping, gene expression, and molecular diagnostic products. The company also offers NGS services, which further strengthens its position in the market.

Thermo Fisher Scientific offers an extensive range of products, including analytical instruments, equipment, reagents & consumables, software & services for research, analysis, discovery, and diagnostics. In addition to a robust product portfolio of NGS sample preparation, the company has a substantial geographic presence. The company launched a number of products in the past three years, including the Oncomine Childhood Cancer Research Assay and the Oncomine Immune Response Research Assay.

With its strong product portfolio, continuous research and development, and wide geographic reach, the company is expected to grow in the NGS sample preparation market.

Read More Details@ 
https://www.marketsandmarkets.com/Market-Reports/ngs-sample-preparation-market-69735098.html